Insights from 2023 SABCS

 

Insights from 2023 SABCS
M

SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in Patients With HER2+/HER2-Low Advanced BC and Pathologically Confirmed Leptomeningeal Carcinomatosis"

By Insights from 2023 SABCS FEATURING Marta Vaz Batista
By Insights from 2023 SABCS FEATURING Marta Vaz Batista
0 views
December 18, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
Videos
20:25
Insights from 2023 SABCS

SABCS 2023 Insights: "Optimizing Adjuvant Endocrine Therapy for…

Feat. V. Stearns
08:23
Insights from 2023 SABCS

SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Ola…

Feat. J. Bajpai
12:21
Insights from 2023 SABCS

SABCS 2023 Insights: "How to Treat TNBC"

Feat. P. Sharma
23:33
Insights from 2023 SABCS

SABCS 2023 Insights: "The Role for Dato-DXd in HR+ mBC"

Feat. S. Tolaney, H. Rugo
26:30
Insights from 2023 SABCS

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & H…

Feat. S. Tolaney, H. Rugo
13:33
Insights from 2023 SABCS

SABCS 2023 Insights: "PREFERABLE-EFFECT Study - Effects of a St…

Feat. A. Hiensch
08:07
Insights from 2023 SABCS

SABCS 2023 Insights: "Protocol-Defined Biomarker Analysis in th…

Feat. D. Stover
17:18
Insights from 2023 SABCS

SABCS 2023 Insights: "ELECTRA Study of Elacestrant in Combinati…

Feat. N. Ibrahim
27:52
Insights from 2023 SABCS

SABCS 2023 Insights: "Innovative Approaches at the Diagnosis an…

Feat. J. Mouabbi
09:41
Insights from 2023 SABCS

SABCS 2023 Insights: "ADAPTcycle Trial - Impact of Age and Ovar…

Feat. O. Gluz
29:40
Insights from 2023 SABCS

Year in Review: Metastatic Breast Cancer

Feat. M. Mac Gregor
10:14
Insights from 2023 SABCS

SABCS 2023 Insights: "A Study of RGT-419B, a Next-Gen CDK4 Inhi…

Feat. S. Wander
04:30
Insights from 2023 SABCS

SABCS 2023 Insights: "VERITAC-3 Study, With a Lead-in, of 1L Ve…

Feat. S. Wander
14:00
Insights from 2023 SABCS

SABCS 2023 Insights: "CDK4/6 Inhibition as a Potential Vulnerab…

Feat. E. Chang
08:45
Insights from 2023 SABCS

SABCS 2023 Insights: "OPERA-01 Study of Palazestrant vs. Standa…

Feat. A. Chan
11:28
Insights from 2023 SABCS

SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk B…

Feat. L. Pusztai
08:41
Insights from 2023 SABCS

SABCS 2023 Insights: "Analysis of ctDNA for the Detection of MR…

Feat. W. Janni
15:13
Insights from 2023 SABCS

SABCS 2023 Insights: "5-Year Outcomes of the IDEA Trial - ET Wi…

Feat. R. Jagsi
03:37
Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in …

Feat. S. Tolaney, H. Rugo
14:01
Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for IO in Early Stage High…

Feat. S. Tolaney, H. Rugo
10:27
Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuv…

Feat. S. Tolaney, H. Rugo
08:54
Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for Pat…

Feat. S. Tolaney, H. Rugo
12:35
Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Appropriate 1L Therapy for ER+…

Feat. S. Tolaney, H. Rugo
04:18
Insights from 2023 SABCS

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebr…

Feat. L. Huppert
05:48
Insights from 2023 SABCS

SABCS 2023 Insights: "Sequential Use of ADCs T-DXd & SG in …

Feat. L. Huppert
09:19
Insights from 2023 SABCS

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…

Feat. K. Kalinsky
03:04
Insights from 2023 SABCS

SABCS 2023 Insights: "The Future of Oral SERDs in Breast Cancer…

Feat. E. Hamilton
03:03
Insights from 2023 SABCS

SABCS 2023 Insights: "CAMBRIA 1 Study of Extended Adjuvant Ther…

Feat. E. Hamilton
02:27
Insights from 2023 SABCS

SABCS 2023 Insights: "HER2CLIMB-05 Trial - Tucatinib or Placebo…

Feat. E. Hamilton
04:03
Insights from 2023 SABCS

SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in…

Feat. M. Vaz Batista
17:35
Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino
10:56
Insights from 2023 SABCS

SABCS 2023 Insights: "CompassHER2 RD Trial - Postneoadjuvant T-…

Feat. C. O'Sullivan
05:40
Insights from 2023 SABCS

SABCS 2023 Insights: "CONFIDENT-B Trial - Clinical Implementati…

Feat. C. Dooijeweert
07:01
Insights from 2023 SABCS

SABCS 2023 Insights: "Clinical Risk Score to Predict Overall Su…

Feat. S. Yang
12:48
Insights from 2023 SABCS

SABCS 2023 Insights: "POSITIVE Trial - Fertility Preservation a…

Feat. H. Azim
13:01
Insights from 2023 SABCS

SABCS 2023 Insights: "Final iDFS Analysis From the NATALEE Tria…

Feat. G. Hortobagyi
09:46
Insights from 2023 SABCS

SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in V…

Feat. H. Rugo
14:15
Insights from 2023 SABCS

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs.…

Feat. H. Rugo
08:24
Insights from 2023 SABCS

SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investi…

Feat. H. Rugo
26:50
Insights from 2023 SABCS

SABCS 2023 Insights: "Controversies in the Surgical Management …

Feat. A. Lucci
04:09
Insights from 2023 SABCS

SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant …

Feat. E. Agostinetto
14:59
Insights from 2023 SABCS

SABCS 2023 Insights: "NRG Oncology/NSABP B-51/RTOG 1304 Trial -…

Feat. T. Mamounas
12:50
Insights from 2023 SABCS

SABCS 2023 Insights: "5-Year Clinical Outcomes of ECOG-AGRIN 41…

Feat. S. Khan
04:35
Insights from 2023 SABCS

SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib + Fulvest…

Feat. S. Hurvitz
09:52
Insights from 2023 SABCS

SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Tra…

Feat. S. Hurvitz